Mair J, Thome-Kromer B, Wagner I, Lechleitner P, Dienstl F, Puschendorf B, Michel G
Department of Medical Chemistry and Biochemistry, University of Innsbruck Medical School, Austria.
Coron Artery Dis. 1994 Oct;5(10):865-72.
As a result of the limited sensitivity and specificity of creatine kinase and lactate dehydrogenase (LDH) as well as their isoenzymes, there is increasing interest in the use of cardiac contractile proteins for the diagnosis of acute myocardial infarction (AMI) and myocardial damage.
This study compared the release of creatine kinase, creatine kinase MB, myoglobin, cardiac troponin I (cTnI), cardiac troponin T (cTnT), cardiac myosin light chain-1 (cMLC-1), and beta-type myosin heavy chains (bMHC) in serial blood samples from 13 patients (10 men, three women; median age 54 years, range 40-74 years) with first-time AMI (11 Q-wave, two non-Q-wave AMI; three anterior and 10 inferior wall AMI). All but one patient received intravenous thrombolytic treatment.
Myoglobin was the first marker to increase in blood after AMI and showed the earliest peak levels, whereas bMHC increased latest, showing the latest peak levels. cTnI and cTnT increased significantly earlier than cMLC-1 and bMHC. cTnI and cTnT increased and reached peak levels parallel to each other, but the latter tended to stay increased longer. cTnT time courses were biphasic in the majority of AMI patients, unlike cTnI time courses. cMLC-1 release was mostly biphasic. cMLC-1 allows diagnosis during the acute phase as well as several days after the onset of AMI. The time courses of bMHC were usually monophasic. Its delayed appearance makes it useful for the diagnosis of remote infarction. In contrast to cTnI and cTnT, cMLC-1 and bMHC time courses were not significantly influenced by early reperfusion.
Our results demonstrate the impact of the intracellular compartmentation of an intramyocardial protein (cytosolic, structurally bound, or structurally bound with soluble pool) on its concentration time course after AMI, particularly on the rapidity of its release.
由于肌酸激酶和乳酸脱氢酶(LDH)及其同工酶的敏感性和特异性有限,人们越来越关注使用心脏收缩蛋白来诊断急性心肌梗死(AMI)和心肌损伤。
本研究比较了13例首次发生AMI患者(10例男性,3例女性;中位年龄54岁,范围40 - 74岁)(11例Q波型,2例非Q波型AMI;3例前壁和10例下壁AMI)系列血样中肌酸激酶、肌酸激酶MB、肌红蛋白、心肌肌钙蛋白I(cTnI)、心肌肌钙蛋白T(cTnT)、心肌肌球蛋白轻链-1(cMLC-1)和β型肌球蛋白重链(bMHC)的释放情况。除1例患者外,所有患者均接受了静脉溶栓治疗。
肌红蛋白是AMI后血液中最早升高的标志物,且峰值水平出现最早,而bMHC升高最晚,峰值水平出现最晚。cTnI和cTnT比cMLC-1和bMHC显著更早升高。cTnI和cTnT升高并达到峰值水平的过程相互平行,但后者升高持续的时间往往更长。与cTnI的时间进程不同,大多数AMI患者的cTnT时间进程呈双相。cMLC-1的释放大多呈双相。cMLC-1可用于AMI急性期及发病后数天的诊断。bMHC的时间进程通常呈单相。其出现延迟使其对陈旧性梗死的诊断有用。与cTnI和cTnT不同,早期再灌注对cMLC-1和bMHC的时间进程没有显著影响。
我们的结果表明,心肌内蛋白质(胞质、结构结合或与可溶性池结构结合)的细胞内分隔对AMI后其浓度时间进程有影响,特别是对其释放速度的影响。